Advertisement
ACOPF vs ACOPY
To understand the difference between The a2 Milk Company Limited (ACOPF) vs. The a2 Milk Company Limited - ADR (ACOPY) it is enough to know the definitions of ADR
ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ACOPF’s FA Score shows that 2 FA rating(s) are green whileACOPY’s FA Score has 2 green FA rating(s).
- ACOPF’s FA Score: 2 green, 3 red.
- ACOPY’s FA Score: 2 green, 3 red.
Price Growth
ACOPF (@Food: Specialty/Candy) experienced а +6.96% price change this week, while ACOPY (@Food: Specialty/Candy) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Food: Specialty/Candy industry was -0.13%. For the same industry, the average monthly price growth was -0.01%, and the average quarterly price growth was -4.20%.
Industries' Descriptions
@Food: Specialty/Candy (-0.13% weekly)A specialty/candy manufacturer specializes in one or more of the following: chocolate, candies, pasta, condiments, seasonings, among other items. Hershey Company, McCormick & Company and J.M. Smucker Company are some of the major firms in this segment. Demand for this industry’s products comes from both institutions/restaurants as well as households.
| ACOPF | ACOPY | ACOPF / ACOPY | |
| Capitalization | 2.46B | 2.46B | 100% |
| EBITDA | 223M | 223M | 100% |
| Gain YTD | 44.110 | 61.230 | 72% |
| P/E Ratio | 30.86 | 28.74 | 107% |
| Revenue | 1.57B | 1.57B | 100% |
| Total Cash | 887M | 887M | 100% |
| Total Debt | 124M | 124M | 100% |
ACOPF | ACOPY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 37 | 17 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 59 Fair valued | 58 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 20 | 20 | |
PRICE GROWTH RATING 1..100 | 37 | 41 | |
P/E GROWTH RATING 1..100 | 23 | 25 | |
SEASONALITY SCORE 1..100 | 34 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ACOPY's Valuation (58) in the null industry is in the same range as ACOPF (59). This means that ACOPY’s stock grew similarly to ACOPF’s over the last 12 months.
ACOPY's Profit vs Risk Rating (100) in the null industry is in the same range as ACOPF (100). This means that ACOPY’s stock grew similarly to ACOPF’s over the last 12 months.
ACOPY's SMR Rating (20) in the null industry is in the same range as ACOPF (20). This means that ACOPY’s stock grew similarly to ACOPF’s over the last 12 months.
ACOPF's Price Growth Rating (37) in the null industry is in the same range as ACOPY (41). This means that ACOPF’s stock grew similarly to ACOPY’s over the last 12 months.
ACOPF's P/E Growth Rating (23) in the null industry is in the same range as ACOPY (25). This means that ACOPF’s stock grew similarly to ACOPY’s over the last 12 months.
| RSI ODDS (%) |
| Stochastic ODDS (%) |
| Momentum ODDS (%) |
| MACD ODDS (%) |
| TrendWeek ODDS (%) |
| TrendMonth ODDS (%) |
| Advances ODDS (%) |
| Declines ODDS (%) |
| BollingerBands ODDS (%) |
| Aroon ODDS (%) |
Advertisement
ACOPF and
Correlation & Price change
A.I.dvisor tells us that ACOPF and ACOPY have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACOPF and ACOPY's prices will move in lockstep.
| Ticker / NAME | Correlation To ACOPF | 1D Price Change % | ||
|---|---|---|---|---|
| ACOPF | 100% | N/A | ||
| ACOPY - ACOPF | 25% Poorly correlated | N/A | ||
| PAVS - ACOPF | 22% Poorly correlated | N/A | ||
| FAMI - ACOPF | 21% Poorly correlated | -1.44% | ||
| AKEJF - ACOPF | 4% Poorly correlated | N/A | ||
| UTZ - ACOPF | -0% Poorly correlated | N/A | ||
More | ||||
ACOPY and
Correlation & Price change
A.I.dvisor tells us that ACOPY and ACOPF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACOPY and ACOPF's prices will move in lockstep.
| Ticker / NAME | Correlation To ACOPY | 1D Price Change % | ||
|---|---|---|---|---|
| ACOPY | 100% | N/A | ||
| ACOPF - ACOPY | 25% Poorly correlated | N/A | ||
| AJINF - ACOPY | 8% Poorly correlated | N/A | ||
| PAVS - ACOPY | 6% Poorly correlated | N/A | ||
| FAMI - ACOPY | 4% Poorly correlated | -1.44% | ||
| UTZ - ACOPY | 4% Poorly correlated | N/A | ||
More | ||||